Eye Health News and Research

Latest Eye Health News and Research

Roche announces acquisition of Signature Diagnostics

Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.

From Roche Sequencing and Life Science 10 Feb 2015

NYEE ophthalmologists offer prevention tips to observe AMD Awareness Month

Macular degeneration is a major cause of irreversible vision loss in the United States and around the world. As many as 11 million Americans have some form of macular degeneration.

9 Feb 2015

Prevalence of geriatric conditions among older, insured patients with diabetes vary little by ethnicity

In one of the first studies of its kind, researchers found that the prevalence of geriatric conditions and diabetic complications among older, insured patients with diabetes did not vary significantly by ethnicity.

9 Feb 2015

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

9 Feb 2015

RPB co-sponsors major IOM study to promote eye health

Research to Prevent Blindness, the leading nonprofit driver of research toward cures and treatments for all blinding disorders, is co-sponsoring a major Institute of Medicine study entitled "Public Health Approaches to Reduce Vision Impairment and Promote Eye Health."

8 Feb 2015

New study shows that 25% of homeless people in Toronto have vision problems

Twenty-five per cent of homeless people surveyed in Toronto had vision problems up to and including blindness, four times higher than the rate of the overall population in North America, a new study by St. Michael's Hospital has found.

6 Feb 2015

Study: Lyme disease costs the U.S. health care system up to $1.3 billion a year

Lyme disease, transmitted by a bite from a tick infected by the Borrelia burgdorferi bacteria, had long been considered easy to treat, usually requiring a single doctor's visit and a few weeks of antibiotics for most people.

6 Feb 2015

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapies addressing high-unmet medical needs, today announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone with Hapten Pharmaceuticals, LLC.

5 Feb 2015

Study: Lower-income students in China have better vision compared to middle-class counterparts

In one of the largest population-based studies ever conducted on nearsightedness in children, researchers have discovered that lower-income students in China have better vision than their middle-class counterparts. Data show that nearsightedness, also called myopia, is twice as prevalent in the middle-income province of Shaanxi compared to the poorer neighboring province of Gansu.

5 Feb 2015

Researchers report that neurons in the brain are connected like a social network

Neurons in the brain are wired like a social network, report researchers from Biozentrum, University of Basel. Each nerve cell has links with many others, but the strongest bonds form between the few cells most similar to each other.

5 Feb 2015

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.

5 Feb 2015

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Three scientists from Keck Medicine of the University of Southern California have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine for research that includes creating a temporary liver for transplant patients, finding novel ways to treat immune disorders and blood diseases and developing a new animal model for exploring diseases like heart failure, diabetes and neurodegenerative diseases.

5 Feb 2015

23andMe announces publication of genome-wide association study of motion sickness

23andMe, Inc., the leading personal genetics company, today announced the publication of the first ever genome-wide association study of motion sickness.

4 Feb 2015

EyeBrain raises €1.3 million ($1.47 million) through crowdfunding

EyeBrain, a company that develops markers of cerebral function for neurological and psychiatric disorders and diseases, today announces the conclusion of a new round of funding. A total of €1.3 million ($1.47 million) has been raised with the support of EyeBrain’s shareholders, the Fonds Régional de Co-Investissement d’Ile-de-France (FRCI, regional joint investment fund for the Ile-de-France or Greater Paris area) and the Anaxago crowdfunding platform.

4 Feb 2015

MGH, MIT researchers reveal how the brain controls different sleep states

Researchers at Massachusetts General Hospital and Massachusetts Institute of Technology have added another piece to the complex puzzle of how the brain controls one of the most essential functions - sleep.

4 Feb 2015

EyePromise® eye vitamins offers education guide to promote awareness on AMD

Due to the aging Baby Boomer population, AMD, or Age-related Macular Degeneration, is expected to double by the year 2020.

4 Feb 2015

Insomnia treatment in veterans linked to significant reduction in suicidal ideation

A new study is the first to show that the treatment of insomnia in veterans is associated with a significant reduction in suicidal ideation.

3 Feb 2015

New test can help measure vital aspects of retinal health

New research published in the February 2015 issue of The FASEB Journal details a test developed using mice that can help measure two important aspects of retinal health--the function of retinal blood vessels and light-detecting cells. This approach opens new possibilities for understanding the molecular changes that occur in retinal disease and for evaluating the benefits of treatment early in the course of disease.

3 Feb 2015

Reversing effects of early stage age-related macular degeneration may be possible

A new technique reported in the February 2015 issue of The FASEB Journal suggests that during early stages, it might be possible to reverse age-related macular degeneration, a leading cause of blindness that is currently irreversible. The treatment involving a nanosecond laser may also have further implications for other eye diseases such as diabetic macular oedema, diabetic retinopathy and retinopathy of prematurity.

3 Feb 2015

Vanderbilt researchers discover new reset button for the brain's master biological clock

The discovery of a new reset button for the brain's master biological clock could eventually lead to new treatments for conditions like seasonal affective disorder, reduce the adverse health effects of working the night shift and possibly even cure jet lag.

3 Feb 2015

Eye Health News and Research

Latest Eye Health News and Research

Roche announces acquisition of Signature Diagnostics

NYEE ophthalmologists offer prevention tips to observe AMD Awareness Month

Prevalence of geriatric conditions among older, insured patients with diabetes vary little by ethnicity

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

RPB co-sponsors major IOM study to promote eye health

New study shows that 25% of homeless people in Toronto have vision problems

Study: Lyme disease costs the U.S. health care system up to $1.3 billion a year

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

Study: Lower-income students in China have better vision compared to middle-class counterparts

Researchers report that neurons in the brain are connected like a social network

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

23andMe announces publication of genome-wide association study of motion sickness

EyeBrain raises €1.3 million ($1.47 million) through crowdfunding

MGH, MIT researchers reveal how the brain controls different sleep states

EyePromise® eye vitamins offers education guide to promote awareness on AMD

Insomnia treatment in veterans linked to significant reduction in suicidal ideation

New test can help measure vital aspects of retinal health

Reversing effects of early stage age-related macular degeneration may be possible

Vanderbilt researchers discover new reset button for the brain's master biological clock

Genetics & Genomics - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in